Navigation Links
OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
Date:10/11/2007

RICHMOND, Texas, Oct. 11 /PRNewswire/ -- (SEND2PRESS NEWSWIRE) -- OCuSOFT Inc., producer of the popular ocular-lid hygiene products, OCuSOFT(R) Lid Scrub(TM) and OCuSOFT(R) Lid Scrub(TM) PLUS, is responding to a recent advertisement released by Advanced Vision Research (AVR) that was found to be misleading.

*(LOGO 72dpi: Send2Press.com/mediaboom/07-0803-Occusoft_72dpi.jpg)

The study, a bacteria time-kill analysis, compared OCuSOFT's Lid Scrub(TM) PLUS Eyelid Cleanser to AVR's SteriLid(R). However, according to OCuSOFT's Executive Vice President, Patrick Witham, "comparing the bacteria kill rate for these two products based on 30-second time point is like comparing apples to oranges." In addition, no evidence was found in AVR's analysis that results were based on independent-lab setting tests.

While both products are eyelid cleansers, they differ in their application and the time in which each product achieves maximum effectiveness. OCuSOFT(R) Lid Scrub(TM) PLUS can be used as a leave-on therapy, while SteriLid(R), according to manufacturer instructions, should be left in place for 60-seconds to achieve maximum effectiveness.

The AVR advertisement compared OCuSOFT(R) Lid Scrub(TM) PLUS and SteriLid(R) at the 30-second time point.

"Unlike SteriLid(R), OCuSOFT(R) Lid Scrub(TM) PLUS was never intended to achieve maximum effectiveness at 30-seconds," Witham said.

OCuSOFT conducted their own study, performed by an independent laboratory, Antimicrobial Test Laboratories, LLC, which tested OCuSOFT(R) Lid Scrub(TM) PLUS after 60-seconds, 60-minutes and 120-minutes. Bacteria reductions were greatest at contact times corresponding with instructions for "leave-on" application. At 120-minutes, at least a 99.9% bacteria reduction was realized on all bacteria, and for some, as much as 99.99%.

For comprehensive, independent laboratory study results, visit: http://www.ocusoft.com/studies/studyresults.html.

"For a true comparison," Witham explained, "AVR should have compared OCuSOFT(R) Lid Scrub(TM) PLUS at the 120-minute time point to SteriLid(R) at the 60-second time point." They would have found that OCuSOFT(R) is more effective.

OCuSOFT(R) Lid Scrub(TM) PLUS was developed with an understanding that most patients, and even health care providers, will not spend 60-seconds applying a solution and rinsing it off.

Emily Sickbert-Bennet, a public health epidemiologist with the University of North Carolina Health Care System and the UNC School of Public Health conducted a study that illustrates that, on average, health care providers spend less than 10-seconds scrubbing their hands.

"This is important information that should not be dismissed. The parallels that can be drawn between these hygiene regimens speak volumes about the likelihood of a patient realistically complying with a 60-second eyelid scrubbing regimen," Witham said. "We developed this practically non- irritating formula in an effort to increase patient compliance. What good is served by recommending a regimen that patients will not adhere to?"

OCuSOFT, Inc. specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They address clinical needs through well-researched and technological solutions, while improving patient compliance.

For a free sample of OCuSOFT(R) Lid Scrub(TM) PLUS, click: http://www.ocusoft.com/sample1.html. For more information about the company and their products, visit: http://www.ocusoft.com.

All trademarks acknowledged.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE OCuSOFT Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Study Refutes Theory on HIVs Effect on White Blood Cells
2. Comparison between warfarin and aspirin
3. Clinical Comparisons Between ADHD Drugs Are Less
4. Differences in brain pattern among liars and cheats in comparison to honest people
5. Rural Canadians travel far for specialists: study
6. A new study surpasses Gene Therapy Hurdle
7. Tomato Sauce reduces Cancer Risk- Study
8. A question on study of Adult Stem Cell
9. Study on obesity and heart failure
10. National Lung Study in the process
11. Marijuana gateway theory strengthened by study of twins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology: